United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News OpenAI’s $6.5bn io acquisition: Why Jony Ive’s design vision could define AI’s hardware era Discover how OpenAI’s $6.5B acquisition of Jony Ive’s hardware startup io is redefining the AI hardware era. First products expected in 2026. byPallavi MadhirajuMay 24, 2025